Validation of the AJCC prognostic stage for HER2-positive breast cancer in the ShortHER trial

BACKGROUND: The 8th edition of the American Joint Committee on Cancer (AJCC) staging has introduced prognostic stage based on anatomic stage combined with biologic factors. We aimed to validate the prognostic stage in HER2-positive breast cancer patients enrolled in the ShortHER trial. METHODS: The...

詳細記述

保存先:
書誌詳細
出版年:BMC Med
主要な著者: Dieci, Maria Vittoria, Bisagni, Giancarlo, Brandes, Alba A., Frassoldati, Antonio, Cavanna, Luigi, Giotta, Francesco, Aieta, Michele, Gebbia, Vittorio, Musolino, Antonino, Garrone, Ornella, Donadio, Michela, Rimanti, Anita, Beano, Alessandra, Zamagni, Claudio, Soto Parra, Hector, Piacentini, Federico, Danese, Saverio, Ferro, Antonella, Cagossi, Katia, Sarti, Samanta, Gambaro, Anna Rita, Romito, Sante, Bazan, Viviana, Amaducci, Laura, Moretti, Gabriella, Foschini, Maria Pia, Balduzzi, Sara, Vicini, Roberto, D’Amico, Roberto, Griguolo, Gaia, Guarneri, Valentina, Conte, Pier Franco
フォーマット: Artigo
言語:Inglês
出版事項: BioMed Central 2019
主題:
Research Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6868696/
https://ncbi.nlm.nih.gov/pubmed/31747948
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12916-019-1445-z
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料